CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 44 enrolled
Drug / intervention
Nestorone® /testosterone gel +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02432261
NCT02432261Phase 1Completed
CompareCT.gov

A Randomized, Two Center, Double-Blind Trial to Evaluate the Pharmacokinetics and Gonadotropin Suppression of Nestorone®-Testosterone (NES/T) Combination Gel in Healthy Men

Kimberly Myer·interventional·Posted May 4, 2015·Updated Feb 13, 2025

In Brief

A Phase 1 clinical trial evaluating Nestorone® /testosterone gel and Testosterone only gel for Healthy. Completed, enrolled 44 participants across 2 sites.

Detailed Summary

This is a prospective, randomized, double-blinded, two-center trial to evaluate the gonadotropin suppressive activity of transdermal treatment with a combined NES/T gel, or T gel alone, for 28 days.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesUnited States
CollaboratorsEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Timeline

Phase 1CompletedFinished
201520162017201820192020202120222023202420252026
First PostedMay 4, 2015
Enrollment StartApr 1, 2015
Primary CompletionMar 1, 2016
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 11.2 years ago

Interventions

Nestorone® /testosterone geldrug

Nestorone® /testosterone combined gel

Testosterone only geldrug

Testosterone only gel